Clinical Trial Update: PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing prasugrel versus ticagrelor in ST-segment elevation myocardial infarction patients with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Brilinta (ticagrelor) (ticagrelor)
• Effient (prasugrel) (prasugrel)

Snippet

Sponsor: Gennaro Sardella | Conditions: ST-Elevation Myocardial Infarction | Phase 3 | Status: COMPLETED